Novartis to buy experimental breast cancer drug for up to $3B
Source: SeekingAlpha
2026-03-20 03:46:01 ET
More on Novartis
- Novartis AG (NVS) Shareholder/Analyst Call Prepared Remarks Transcript
- Novartis: Value Price, Growth Pipeline
- Novartis AG 2025 Q4 - Results - Earnings Call Presentation
- Novartis picks Texas to build next radioligand therapy site
- Trump says tariffs prompt Novartis to expand U.S. manufacturing
Read the full article on Seeking Alpha
For further details see:
Novartis to buy experimental breast cancer drug for up to $3B
Novartis AG
NASDAQ: NVS
NVS Trading
-0.26% G/L:
$150.47 Last:
852,043 Volume:
$151.84 Open:
NVS Latest News
February 24, 2026 04:52:00 pm
Could Novartis Stock Quietly Help You Build a Millionaire Retirement Portfolio?
NVS Stock Data
$303,205,301,793
1,889,070,162
N/A
868
N/A
Pharmaceuticals
Healthcare
CH
Basel
